Variable | Evaluable N = 44 | Starting dose ≤ 5 mg/die (N = 14) | Starting dose > 5 mg/die (N = 30) |
---|---|---|---|
Any reduction | 22 (50%) | 8 (57.1%) | 14 (46.7%) |
Reduction from baseline | |||
100% | 19 (43.2%) | 6 (42.9%) | 13 (43.3%) |
≥ 90% | 19 (43.2%) | 6 (42.9%) | 13 (43.3%) |
≥ 75% | 20 (45.5%) | 6 (42.9%) | 14 (46.7%) |
≥ 25% | 21 (47.7%) | 7 (50%) | 14 (46.7%) |
No reduction | 22 (50%) | 6 (42.9%) | 16 (53.3%) |